Category: ACN Newswire

Vancouver, BC, June 11, 2026 - (ACN Newswire via SeaPRwire.com) - Gold Basin Resources Corporation ("Gold Basin") (TSXV:GXX) is pleased to announce that it has completed the previously announced arrangement (the "Arrangement") involving Gold Basin and CANEX Metals Inc. ("CANEX").In accordance with the terms of the Arrangement, CANEX acquired all the remaining issued and outstanding common shares in the capital of Gold Basin (each a "Gold Basin Share") for 0.592 of a common share of CANEX per Gold Basin Share.The Arrangement was originally announced on May 12, 2026, and was approved by Gold Basin's shareholders at a special meeting held on June 4, 2026 (the "Meeting"). Gold Basin obtained a final order in respect of the Arrangement from the Supreme Court of British Columbia on June 9, 2026.Additional information regarding the terms of the Arrangement is set out in Gold Basin's management information circular dated May 14, 2026, filed in connection with the Meeting under Gold Basin's profile on SEDAR+ at www.sedarplus.ca.Early Warning DisclosureImmediately prior to the completion of the Arrangement, CANEX had beneficial ownership of, and exercised control and direction of 70,088,199 Gold Basin Shares, representing approximately 51.86% of the then issued and outstanding Gold Basin Shares. As a result of the Arrangement, CANEX beneficially owns, or exercises control and direction over, 104,742,818 Gold Basin Shares, representing 100% of the issued and outstanding Gold Basin Shares.An early warning report will be filed in accordance with applicable securities laws and will be available on CANEX's SEDAR+ profile at www.sedarplus.ca. To obtain a copy of the early warning report, please contact the secretary of CANEX, Barbara O'Neill at +1-403-233-2636.CANEX's head office is located at 734 - 7th Avenue, Suite 1620, Calgary, Alberta, T2P 3P8, Canada.About Gold Basin Resources CorporationGold Basin Resources Corporation holds the Gold Basin Project in Mohave County Arizona. The project hosts large, mineralized trends containing near surface oxide gold mineralization and has seen over 800 historic and current drill holes into mineralized deposits up to 1.7 kilometres in length."Shane Ebert"Shane Ebert, President, Chief Executive Officer and DirectorFor Further Information Contact:Shane Ebert at 1.250.964.2699 orJean Pierre Jutras at 1.403.233.2636Web: http://www.canexmetals.caNeither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.Forward-Looking StatementsThis news release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always stating that certain actions, events or results "may", "can", "shall" or "will" be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements.In this news release, forward-looking statements relate to, among other things, statements regarding the filing of CANEX's early warning report. These forward-looking statements are not guarantees of future results and involve risks and uncertainties that may cause actual results to differ materially from the potential results discussed in the forward-looking statements.In respect of the forward-looking statements, Gold Basin has relied on certain assumptions that it believes are reasonable at this time. Accordingly, readers should not place undue reliance on the forward-looking statements and information contained in this news release concerning these times.Risks and uncertainties that may cause such differences include but are not limited to: the possibility that legal proceedings may be instituted against CANEX, Gold Basin, and/or others relating to the Arrangement and the outcome of such proceedings; risks relating to the failure to obtain necessary regulatory and stock exchange approvals; other risks inherent in the mining industry. Gold Basin disclaims any responsibility to update these forward-looking statements, except as required by applicable laws.SOURCE: Gold Basin Resources Corporation Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

LAS VEGAS, NV, June 10, 2026 - (ACN Newswire via SeaPRwire.com) - Agassi Sports Entertainment Corp. (OTCID:AASP) ("ASE" or the "Company"), a sports, media, and technology platform focused on the global racket sports ecosystem and built around the iconic brands of Andre Agassi and Stefanie Graf, today announced that it has entered into a name and likeness license agreement with renowned tennis coach Darren Cahill. As a member of the team, Cahill will collaborate with ASE across a range of strategic initiatives, including the Company's previously announced Agassi Intelligence technology platform being developed in partnership with IBM, original content creation, media opportunities and other global growth initiatives designed to expand access to world-class coaching and deepen fan engagement across racket sports.Cahill, a former professional player and one of the most accomplished coaches in tennis history, has guided multiple Grand Slam champions and former world No. 1 players, including Andre Agassi, Jannik Sinner, Simona Halep, and Lleyton Hewitt. His addition further strengthens ASE's growing network of elite athletes, coaches and industry leaders working together to build a next-generation sports media and technology platform."For decades, Darren has been recognized as one of the most respected and innovative coaches in the sport," commented Ronald Boreta, Chief Executive Officer of Agassi Sports Entertainment. "His experience developing champions, his credibility throughout the tennis community and his passion for growing the game make him an ideal partner as we continue building our technology, content and media platforms on a global scale.""Darren has had a profound impact on my career and on the sport of tennis," said Andre Agassi, Co-Founder of Agassi Sports Entertainment. "What makes Darren special isn't just his knowledge of the game-it's his ability to connect with people, communicate complex ideas simply and help athletes unlock their potential. Bringing Darren into the Agassi Sports Entertainment family is a natural extension of a relationship built on trust, innovation and a shared belief that great coaching should be more accessible to players everywhere.""I've been fortunate to work with some incredible athletes throughout my career, and I've always believed that great coaching can change lives," said Darren Cahill. "Agassi Sports Entertainment is bringing together technology, media and some of the most recognizable names in sports to create something unique. I'm excited to work alongside Andre, Stefanie and the entire ASE team as we explore new ways to educate, inspire and connect with players and fans around the world."ASE previously announced a multi-year collaboration with IBM to develop Agassi Intelligence, an AI-powered digital platform designed to bring advanced coaching insights, premium content, commerce, and community experiences together in a single destination for racket sports enthusiasts worldwide. Cahill is expected to contribute coaching expertise and strategic insights that will help shape future platform experiences and content offerings.Additional announcements regarding Agassi Intelligence, platform features, and other initiatives involving Darren Cahill are expected in the coming months.About Agassi Sports Entertainment Corp.Agassi Sports Entertainment Corp. (OTC:AASP) is a sports entertainment, content, media, and technology company focused on developing products, platforms, and experiences across racket sports. The Company seeks to collaborate with leading global brands and iconic athletes to grow participation, engagement, and long-term shareholder value. For more information about Agassi Sports Entertainment, visit www.agassisports.com.Forward-Looking StatementsThis press release includes "forward-looking statements", including information about Agassi Sports Entertainment's future expectations, plans, and prospects. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue" and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results and, consequently, you should not rely on these forward-looking statements as predictions of future events. Factors that could cause actual results to differ materially include, without limitation: (a) the timing, cost, funding availability, anticipated benefits and successful implementation of the Company's planned digital platform, mobile application and world series of pickleball events; (b) the Company's ability to raise sufficient capital to fund operations, satisfy obligations to third-party service providers, support growth initiatives and continue as a going concern, the terms on which such financing may be available, and potential dilution resulting therefrom; (c) intense competition in the court sports, digital platform and live event industries and the Company's ability to compete effectively and achieve market acceptance for its products and services; (d) the Company's limited operating history, lack of significant revenues, history of losses, unproven business model and lack of experience in the court sports industry, and the risk that it may not achieve profitability or successfully execute its business plan; (e) the Company's dependence on its management team and key personnel, the absence of employment agreements with certain personnel, and its ability to manage future growth and operational complexity; (f) the Company's reliance on the continued involvement, reputation and brand recognition of Andre Agassi, Darren Cahill, Stefanie Graf, and related strategic relationships; (g) the Company's planned concentration in the pickleball and padel industries and its ability to capitalize on anticipated industry growth trends; (h) adverse economic conditions, including inflation, reduced consumer and corporate discretionary spending and capital markets conditions, which could negatively affect demand, operating results, financial condition, cash flows and the Company's ability to raise capital; (i) risks related to the Company's planned use of artificial intelligence, cybersecurity incidents, disruptions to information systems, evolving privacy and data protection laws, and unauthorized access to customer data; (j) the Company's ability to secure suitable venues, sponsorships, participants, permits and approvals and to successfully execute and scale planned events and operations; (k) claims, liabilities, injuries, accidents or other risks arising from the construction or operation of potential facilities, live events, or the use of future premises, equipment or services, and the adequacy of insurance coverage; and (l) the Company's ability to satisfy Nasdaq's quantitative listing standards, Nasdaq's discretionary approval of the listing of the Company's common stock based on qualitative factors, and the timing associated therewith. Additional risks are described in the Company's filings with the Securities and Exchange Commission, including its periodic reports, which are available at www.sec.gov. Forward-looking statements speak only as of the date made, and the Company undertakes no obligation to publicly update or revise any forward-looking statement, except as required by law.Investor Contact:FNK IR - Matt Chesler, CFA / Rob Finkinvestors@agassisports.comMedia Contact:MKTG - Stephanie Rudnick / Emmanuel Cavaleristephanie.rudnick@mktg.com / emmanuel.cavaleri@mktg.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

BANGKOK, June 10, 2026 - (ACN Newswire via SeaPRwire.com) - True Internet Data Center, or True IDC, Thailand's largest data center operator, backed by Charoen Pokphand Group (CP Group) and Global Infrastructure Partner (GIP), a part of BlackRock, has announced a landmark achievement in winning the 'Digital Infrastructure of the Year' award at the IJGlobal Awards, a globally recognized institution for infrastructure and project finance intelligence. This recognition not only reflects the organization's success but also signals Thailand's capabilities on the international stage.The 'Digital Infrastructure of the Year' award affirms the stature of the AI Hyperscale Data Center project, spanning over one hundred megawatts in the Eastern Economic Corridor (EEC), Rayong Province, as a world-class development drawing global attention. The project features a robust financial and investment structure, developed under advanced data center technology across all dimensions and international sustainability and environmental standards. The first phase is expected to go live in Q3 2026. The project is also among those receiving BOI investment promotion, with a total value exceeding THB 77 billion.Thanasorn Jaidee, President of True IDC, commented, “The IJGlobal Award is proof of the strength of this mega data center project, both in financial structure and operations, which True IDC has been developing since 2025. This project is a magnet for investor confidence worldwide and marks a turning point that firmly positions Thailand as a regional technology infrastructure hub, generating substantial long-term economic value. True IDC extends its gratitude to all partners who have driven this project forward, securely, safely, and sustainably, to meet every challenge of the digital era".Panuwat Hirunpatawong, Chief Investment Officer of True IDC added, “This award reflects our proven ability to structure and finance world-class data center projects. As the country's longest-established data center provider operating in one of the fastest-growing data center markets in the region, we combine that financial capability with unparalleled operational expertise and local market knowledge. True IDC is well positioned to support hyperscalers as they establish and grow their presence in Thailand.”This achievement at the IJGlobal Awards confirms that True IDC is ready to lead Thailand toward becoming a prominent digital hub in the Asia-Pacific region.About True IDCTrue Internet Data Center Co., Ltd. (headquartered in Bangkok, Thailand), operating under CP Group and Global Infrastructure Partner (GIP), a part of BlackRock, is Thailand's largest data center services provider. Specializing in AI Hyperscale Data Center services designed for advanced computing workloads and the expansion of cloud and artificial intelligence, True IDC manages facilities in key business districts domestically and internationally, certified to the highest international standards. It is recognized by leading global organizations and serves as a key driver of Thailand's and ASEAN's digital economy.For more information: https://www.trueidc.com/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SINGAPORE, June 10, 2026 - (ACN Newswire via SeaPRwire.com) - As organisations across Singapore and the wider ASEAN region accelerate cloud adoption, hybrid work and digital transformation, many continue to grapple with fragmented security environments, growing alert volumes, and increasing pressure to improve visibility and operational efficiency.To address this and as part of its continuing investments in strengthening cyber resilience across the region, Fortinet has launched a new FortiNDR Cloud Point-of-Presence (PoP) in Singapore, bringing cloud-delivered network detection and response capabilities closer to customers in the region.The move reflects a broader cybersecurity trend: organisations are looking for stronger visibility across on-premises, cloud, hybrid and operational technology environments as attackers use legitimate tools and trusted platforms to move laterally and remain undetected for longer periods. Fortinet's new Singapore-based PoP is designed to help regional customers improve detection, speed up response and support operational requirements around performance and regional compliance.Visibility becomes the front lineSecurity teams are no longer dealing with threats only at the perimeter. Modern attacks increasingly unfold across distributed networks, unmanaged devices, Internet of Things (IoT) assets and cloud workloads, making it harder for traditional approaches alone to deliver consistent visibility.FortiNDR Cloud is built to address that challenge by using artificial intelligence (AI)-powered analytics, behavioural detection and FortiGuard Labs threat intelligence to analyse network traffic and metadata for signs of suspicious activity. By identifying anomalous behaviour that may blend into ordinary business operations, the platform aims to help organisations detect threats earlier and reduce attacker dwell time.From detection to faster responseThe Singapore PoP also highlights a shift in how organisations are approaching security operations. Rather than simply adding more tools, many are looking for platforms that can streamline investigation and response while giving analysts a clearer view across complex estates.FortiNDR Cloud includes AI-powered guidance, natural language capabilities and up to 365 days of retrospective hunting, allowing security operations centre teams to investigate incidents more efficiently and look back across historical network activity when needed. This is particularly relevant as organisations explore how to operationalise AI in security operations without losing control of fragmented environments and incomplete data.Local infrastructure, regional resilienceHosting the FortiNDR Cloud PoP in Singapore gives organisations in ASEAN and Asia Pacific access to security services delivered closer to where they operate, which can support latency, operational efficiency and regional compliance needs. The launch also expands Fortinet's broader cybersecurity infrastructure footprint in Asia Pacific as demand grows for localised cloud-delivered security services."Organisations across ASEAN and Asia Pacific are operating in increasingly complex digital environments, where security teams must manage growing cloud adoption, hybrid operations and rapidly evolving cyber risks. At the same time, many organisations are looking to leverage AI to improve security outcomes, but fragmented environments and limited visibility continue to create operational challenges," said Jack Chan, VP, Product Management and Field CTO APAC, Fortinet. "Fortinet's continued investment in Singapore reflects our long-term commitment to helping customers build stronger cyber resilience through integrated, AI-powered security capabilities delivered closer to where they operate."Jess Ng, Country Head, Singapore and Brunei, Fortinet, said: "In Singapore, organisations are increasingly prioritising visibility, operational efficiency, and faster response as cyber threats become more sophisticated and difficult to detect. The new Singapore-based FortiNDR Cloud PoP brings advanced detection and response capabilities closer to customers, helping them improve visibility across distributed environments, strengthen operational resilience, and support faster, more efficient security operations."About FortinetFortinet is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere our customers need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet's solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. Collaboration with esteemed organizations from both the public and private sectors, including Computer Emergency Response Teams (“CERTS”), government entities, and academia, is a fundamental aspect of Fortinet’s commitment to enhance cyber resilience globally. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.Media Contact:Lim Seng Jinlim.sengjin@priorityconsultants.com Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Jun 10, 2026 - (ACN Newswire via SeaPRwire.com) - (Hong Kong, 9 June 2026) – YesStyle, the global online beauty retailer under YesAsia Holdings Limited (“YesAsia Holdings”, together with its subsidiaries, the “Group”) (02209.HK), has announced the launch of its new physical retail store in the US. Located on the main level of Great Mall in Milpitas, in the heart of the San Francisco Bay Area, the new concept store not only marks a significant step in bringing the latest K-beauty trends to a broader US audience, but also represents a major strategic milestone in advancing the Group’s B2C-B2B dual-engine strategy to expand market share in North America.Driving O2O Synergy: Expanding Offline Reach to Complement B2C StrategyCelebrating 20 years of delivering trending Asian products worldwide, YesStyle has transformed 1,500 square feet into an immersive retail fantasy. Serving as a strategic extension of the Group’s core B2C business, this new physical footprint enhances offline visibility and reaches a wider demographic of consumers who value hands-on product discovery and immediate purchase. The store offers a “Yesful playground” where beauty lovers can connect with over 60 Asian brands, featuring interactive makeup stations with beloved K-beauty labels like UNLEASHIA, dasique, fwee, and rom&nd, alongside a customizable mask bar. This experiential retail environment functions as a powerful, culturally rich marketing engine, generating offline brand awareness and foot traffic that seamlessly feeds into the digital platform, creating a complementary offline-to-online (O2O) loop that supports repeat purchases and maximizes customer lifetime value (LTV).Mr. Joshua Lau, Founder, Executive Director and Chief Executive Officer of YesAsia Holdings said: “The launch of YesStyle’s retail store marks a significant milestone for our brand, as we bring our top-tier and bestselling K-beauty products, along with advanced skin care innovation, into an offline setting for customers in the Bay Area. The Bay Area holds a special place in our history as the city where the Group was founded and where our first office was established. Opening our first YesStyle beauty retail store here feels like coming home and reinforces our commitment to continue innovating and delivering exceptional experiences to our customers, both online and offline.”Empowering the B2B Wholesale Business AsiaBeautyWholesale (ABW) GrowthThis physical retail expansion also creates substantial value for YesAsia Holdings’ B2B operations, ABW. By physically showcasing a curated yet expansive selection of bestselling Korean beauty brands, including SKIN1004, Medicube, Anua, Dr. Althea, Beauty of Joseon, COSRX, and more, in a premium US retail environment, YesStyle acts as an effective market-testing ground. The elevated brand awareness and consumer validation generated at the retail level will bolster confidence among other local US retailers and distributors, effectively catalyzing B2B orders and driving synergistic growth across both of the Group’s core business modules. Photo 1: YesStyle brings K-beauty into the US retail market with the opening of its retail location at the Great Mall, Milpitas. Photo 2: The interior of the new YesStyle flagship store, showcasing its signature “Colorful Marshmallow World” design. Photo 3: The interior showcases an extensive range of trending skin care and cosmetics from iconic Asian labels.About YesAsia Holdings Limited (02209.HK)Established in 1997, YesAsia Holdings is a leading e-commerce platform operator recognized for its expertise in identifying and procuring quality Asian beauty, fashion, lifestyle and entertainment products. Headquartered in Hong Kong, the Group deliver products promptly and efficiently to a global audience through its strong ties with over 400 leading Asian beauty brand and supplier partners. The Group operates three major platforms: YesStyle, an e-commerce B2C platform for serving the increasingly popular Asian beauty, fashion and lifestyle products, particularly Korean beauty products; AsianBeautyWholesale, a B2B platform for Asian beauty products; and YesAsia, an e-commerce retail platform for entertainment products. YesAsia Holdings is a constituent of the MSCI Hong Kong Micro Cap Index.For more information, please visit the Group’s official website: https://www.yesasiaholdings.com/About YesStyleYesStyle, a global B2C online retailer under YesAsia Holdings Limited. (02209.HK), is the go-to destination for the largest selection of authentic Asian beauty, fashion, and lifestyle products. As an authorized retailer of 400+ premium K-beauty brands, YesStyle aims to help everyone find their 'yes!' through innovative beauty inspired by Asia, friendly guidance and smart prices since 2006. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

ATLANTA, GA & SYDNEY, AU, June 9, 2026 - (ACN Newswire via SeaPRwire.com) - Haven Safety AI, the AI-native platform for incident investigation and root cause analysis in high-risk operations, today announced the availability of its platform in Australia, marking the company's first international expansion.The launch brings Haven's safety intelligence platform to Australian organisations with capabilities designed for the country's distinct EHS, Work Health and Safety, data residency, and enterprise security requirements. Haven's knowledge graph has been localised to support Australian safety terminology, regulatory context, jurisdictional considerations, incident investigation workflows, and root cause analysis practices, enabling teams to conduct AI-assisted investigations with local operating context from the start.The Australian release also includes support for local data residency requirements and security controls designed for organisations managing sensitive operational, workforce, and safety information."Australia was the clear choice for Haven's first international market," said Joseph Hanna, Co-Founder and CEO of Haven Safety AI. "The country has a deep and serious safety culture, especially across high-risk industries, and a strong willingness to adopt innovation when it can improve how work is actually done. We built Haven's Australian availability around that reality: local WHS context, local data residency expectations, and the governance safety leaders need to use AI responsibly in incident investigation and RCA."Haven helps organisations move beyond digitised forms and static investigation templates by combining structured workflows, AI-assisted analysis, and a continuously learning knowledge graph. The platform supports safety teams through evidence collection, event reconstruction, causal analysis, corrective action development, investigation quality review, and enterprise-level learning across incidents.For Australian organisations, Haven's localised platform is designed to help teams:Conduct incident investigations and RCA with Australia-specific WHS and EHS contextImprove investigation consistency across sites, teams, and business unitsIdentify recurring causal patterns, failed controls, and emerging operational risksStrengthen corrective action quality and accountabilityMaintain governance, auditability, and security for sensitive safety dataSupport local data residency expectations for Australian operationsThe Australian launch comes as safety leaders increasingly evaluate AI as a core layer of the next generation of EHS technology."Our team evaluated Haven as part of a consulting engagement supporting a major Australian energy company in selecting and deploying AI-enabled investigation and learning capability. We were impressed," said Cam Stevens, Founder and CEO of Pocketknife Group. "Haven has been thoughtful about how AI and humans work together across the investigation and learning workflow. Their focus on helping organisations learn from incidents consistently and at scale is exactly where AI in workplace health and safety needs to go. We're excited to see Haven in the Australian market."Pocketknife Group is an Australia based consultancy that works with organisations navigating safety innovation, digital transformation, critical risk management, and the integration of AI and emerging technology into safety-critical systems."Haven's expansion into Australia is about more than making the product available in a new geography," Hanna added. "It is about building a platform that understands the local regulatory environment, respects local data requirements, and helps Australian safety teams turn every investigation into a stronger prevention system."Haven is available now for Australian enterprise customers across energy, utilities, infrastructure, construction, manufacturing, logistics, mining, and other high-risk sectors.For more information, visit www.havensafety.com.About HavenHaven Safety AI, a product of Haven Safety Corporation, provides an AI-native platform for incident investigations, root cause analysis, and proactive risk reduction. By combining artificial intelligence with a structured industry knowledge graph, Haven helps organizations capture frontline insights, analyze systemic causes, and continuously improve safety performance. For more information, visit www.havensafety.com.Media contact:Madeleine Moenchmadeleinem@accessnewswire.comSOURCE: Haven Safety Corporation Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

WEST PALM BEACH, FL AND LONDON, UK, June 9, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), returned for the third consecutive year as the Official Apparel and Jersey Partner of Chestertons Polo in the Park, bringing together world-class competition, sport-inspired fashion, thrilling entertainment, and memorable lifestyle experiences for one of London's most anticipated summer sporting events. Held June 5-7, 2026, at Hurlingham Park in central London, the three-day festival welcomed more than 30,000 attendees for a celebration of the sport of polo in one of the world's most iconic urban settings.The Red Sea Global Team Riyadh and the Disney+ Team Rivals fighting for the ball at Chestertons Polo in the ParkAs the Official Apparel and Jersey Partner, U.S. Polo Assn. outfitted all teams throughout the tournament with custom-designed performance jerseys while also providing staff uniforms and immersive brand experiences designed to connect consumers to the authentic roots of the brand and the sport of polo.Throughout the weekend, U.S. Polo Assn. created its largest presence yet at Chestertons Polo in the Park with a dedicated activation showcasing polo shirts and sport-inspired collections for men, women, and children, alongside an interactive photo wall and other fan experiences. Players distributed branded U.S. Polo Assn. caps to spectators directly from horseback after matches each day, creating memorable moments that brought fans closer to the action.For the first time, attendees also experienced "The Divot Stomp," U.S. Polo Assn.'s signature cocktail, offered exclusively in VIP hospitality areas and served during the event's iconic halftime tradition each day. The specialty drink, served in reusable aluminum cups with custom polo mallet stirrers, added another interactive element to the weekend celebration, with fans taking them home as keepsakes.The three-day polo festival also provided the perfect stage for U.S. Polo Assn.'s global polo shirt campaign, "An Icon Born from the Game," highlighting the authentic connection between the brand's most recognizable product and its origins in the sport of polo. Throughout the festival grounds, attendees experienced activations centered around the iconic polo shirt while exploring new seasonal collections inspired by sport and style."Chestertons Polo in the Park captures everything that makes the sport of polo special with competition, fashion, entertainment, accessibility, and community, all in the heart of one of the world's most vibrant cities," said J. Michael Prince, President and CEO of USPA Global, the company that manages and markets the multi-billion-dollar U.S. Polo Assn. brand. "As a brand born from the sport, our continued partnership allows us to connect with consumers in an authentic way while celebrating the heritage, energy, and global appeal that define both London and the sport of polo."Since launching in 2009, Chestertons Polo in the Park has evolved into one of the world's largest polo lifestyle festivals and remains the only polo tournament played in central London. The 2026 edition featured six teams representing global cities and brands at the event, including Disney+ Team Rivals, New Equity Team London, IBV Gold Team Cape Town, who's roster included U.S. Polo Assn. Brand Ambassadors Nico and Lucas Escobar, Kohn, Loeb & Co. Team Zurich, Icon Global/AMASE Team Texas, and the Red Sea Global Team Riyadh. The festival's daily themes include International Day on Friday, where Team England faced Team South Africa, followed by Ladies Day on Saturday and Finals and Family Day on Sunday.During the 2026 Chestertons Polo in the Park Final, the Red Sea Global Team Riyadh played against the Icon Global/AMASE Team Texas in a close game resulting in a 4-4 tie by the end of the final chukker. After an exciting run down, the Red Sea Global Team Riyadh took their third win in a row at Chestertons Polo in the Park, and teammate Cesar Crespo earned MVP."As the strategic partner for U.S. Polo Assn. in the United Kingdom, Chestertons Polo in the Park continues to be an important platform to showcase the authentic connection between our brand and the sport of polo," said Boo Jalil, CEO of Brand Machine Group, U.S. Polo Assn.'s licensing partner in the United Kingdom. "This event represents everything consumers love about U.S. Polo Assn., such as the heritage, style, accessibility, and fun, which allows us to engage directly with fans in one of our most important global markets."The United Kingdom remains a significant growth market for U.S. Polo Assn., which continues expanding retail distribution and consumer reach throughout the region. Consumers can explore the latest collections and sport-inspired styles at www.uspoloassn.co.uk."Chestertons Polo in the Park was created to make the sport of polo more accessible and bring new audiences closer to the game, and U.S. Polo Assn. continues to be an important part of that vision," said Rory Heron, Managing Director of Sportgate International and founding organizer of the event. "Their authentic connection to the sport, combined with engaging fan experiences and innovative activations, helps create the unique atmosphere that makes this event one of London's standout summer occasions."Beautiful guests posing at Chestertons Polo in the Park photo wallU.S. Polo Assn.'s merchandise tent at the three-day polo lifestyle festival, Chestertons Polo in the Park, in Downtown LondonPhoto Credit: Spot MeAbout U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, Star Sports in India, and BeIn Sports in the Middle East now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has recently been named one of USA Today's Most Trusted Brands and has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.About Brand Machine Group (BMG)BMG is an international leader in fashion innovation which has established itself as a vertical manufacturer and global licensing specialist with over four decades of industry experience. Partnering with recognized market leaders, BMG manages a seamless and collaborative process of designing, manufacturing, and delivering quality products while championing the DNA of a diverse portfolio of brands, spanning fashion, sports, outdoor, and homeware including adult fashion, kidswear, and accessories.BMG's portfolio of brands includes U.S. Polo Assn. Penfield, New Balance Kids, Duchamp, Jack Wills, Flyers American Born, Lee Kids, Peckham Rye, Wrangler Kids, Juicy Couture, Franklin & Marshall, Elle Junior and Ben Sherman. BMG reaffirms its commitment to upholding sustainable and ethical business practices by ensuring full transparency throughout its global supply chain, aligning with the ETI Base Code.Visit brandmachinegroup.com and follow @brandmachinegroup. For appointments contact, sales@brandmachinegroup.comAbout Sportgate InternationalSportgate International is an international event management and sports marketing agency. Established in 2015, Sportgate International now owns events and consults with companies, luxury brands, world-class venues, tourism boards, and rights holders requiring sponsorship and event expertise. Sportgate International owns a portfolio of luxury events which encourages and enables the world's best brands, top companies, and individuals to further their corporate or personal objectives. The company also works with some of the most high-profile venues in the world, offering original content that enables networking and marketing to specific audiences.For more information, visit sportgateint.com.For Further Information, Contact:Stacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comShannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, British Columbia, June 9, 2026 - (ACN Newswire via SeaPRwire.com) - Doubleview Gold Corp. (TSXV: DBG) (OTCQB: DBLVF) (FSE: 1D4) ("Doubleview" or the "Company") is pleased to report assay results that extend Hat's gold-copper mineralization approximately 150m beyond the known resource envelope, opening a new exploration frontier the Company calls the Far East Zone. Drill holes H102-H108, completed during the Company's 2025 drill program at its 100%-owned Hat Project in northwestern British Columbia, also returned standout gold-enriched intervals including 8.0m grading 4.04 g/t Au and 112.0m grading 0.40 g/t Au.The 2025 drill program tested two distinct eastern areas of the Hat system, 233m apart. Holes H102-H105 add drill density and continuity data within and below the eastern side of the 2026 Preliminary Economic Assessment (PEA) pit shell, reinforcing the geological interpretation that underpins the Company's existing resource. Holes H106-H108 delivered the headline result: a new mineralized corridor, the Far East Zone, identified approximately 150m east of the current resource envelope, with elevated gold grades pointing toward a distinct and compelling geological target for future drilling.Drill holes H102-H108 were not completed in time to be incorporated into the Mineral Resource Estimate (MRE) with an effective date of February 4, 2026 or the PEA disclosed in March 2026. These assays do not constitute an updated MRE, mineral reserve estimate, pit optimization or economic analysis. The Company expects to evaluate the results in future mineral resource modelling and future engineering studies.CEO CommentFarshad Shirvani, President and CEO of Doubleview Gold Corp., commented: "These results demonstrate that the Hat Project continues to grow beyond the mineralized footprint used in our recently completed Mineral Resource Estimate and Preliminary Economic Assessment. The discovery of the Far East Zone approximately 150 metres beyond the current mineralization envelope, together with multiple broad mineralized intervals and significant gold enrichment, reinforces our belief that Hat remains substantially underexplored. Importantly, none of these holes were included in the February 2026 Mineral Resource Estimate or March 2026 PEA. We believe these results further highlight the scale potential of the Hat Project and provide compelling targets for future resource growth and engineering studies."HighlightsFar East Zone step-out: H106-H108 identify assay-supported mineralization approximately 150m east of the existing mineralization envelope. Follow-up drilling is required to determine geometry, continuity and extent.Two eastern data areas: the H102-H105 and H106-H108 platforms are approximately 233m apart. Figures 1 to 4 illustrate the separation between the East Zone and the Far East Zone.Gold-enriched intervals: H106-H108 show a higher gold contribution in several intervals, including 8.0m grading 4.04 g/t Au in H106 and 112.0m grading 0.40 g/t Au in H108.Resource confidence work: H102-H105 provide added drill density and continuity information for future geological modelling. The assays support future assessment of mineral resource classification. They do not, by themselves, establish a change in Measured, Indicated or Inferred mineral resource quantities or classifications.CuEq values exclude scandium oxide: reported Sc2O3 grades remain outside the CuEq calculation and are shown separately in Table 1.Selected Assay ResultsH102: 693.0m grading 0.20% CuEq,including 17.5m grading 1.25% CuEq.H103: 531.0m grading 0.20% CuEq,including 145.0m grading 0.40% CuEq and 26.1m grading 0.96% CuEq.H104: 259.0m grading 0.39% CuEq,including 142.0m grading 0.47% CuEq and23.0m grading 1.22% CuEq.H105: 427.1m grading 0.21% CuEq,including 71.2m grading 0.35% CuEq.H106: 444.0m grading 0.29% CuEq andan overlapping interval of 403.0m grading 0.31% CuEq,including 132.0m grading 0.51% CuEq,48.0m grading 1.00% CuEq,16.6m grading 2.02% CuEq and8.0m grading 3.93% CuEq.H107: 530.2m grading 0.20% CuEq andan overlapping interval of 463.0m grading 0.21% CuEq,including 22.2m grading 0.57% CuEq.H108: 135.0m grading 0.39% CuEq,including 112.0m grading 0.43% CuEq, anda separate interval of 75.0m grading 0.25% CuEq.All reported intervals are drill core lengths. True widths have not been determined. Complete assay intervals are presented in Table 1.Table 1: Summary of H102-H108 Drill Core Assay InterceptsDDHNoteFrom (m)To (m)Length (m)CuEq (%) not incl Sc2O3Au (g/t)Cu (%)Ag (g/t)Co (g/t)Sc2O3 (g/t)H102 6.0699.0693.00.200.090.100.145449.7H102incl.246.0699.0453.00.230.100.120.165554.1H102incl.252.0257.05.00.830.370.430.4120128.4H102incl.348.0696.0348.00.250.110.130.194753.9H102incl.348.0394.046.00.350.130.200.197862.1H102incl.527.0528.01.05.462.253.3011.0029228.5H102incl.681.5699.017.51.250.670.640.696044.1H103 9.0540.0531.00.200.100.090.156739.8H103incl.39.0119.080.00.290.200.090.305538.1H103incl.236.3532.0295.70.240.110.110.138140.9H103incl.387.0532.0145.00.400.190.200.218542.1H103incl.396.0540.0144.00.400.190.200.207842.2H103incl.399.0489.090.00.500.270.240.248146.2H103incl.406.5432.626.10.960.630.380.2510051H104 12.051.039.00.220.140.080.274737.3H104 425.0684.0259.00.390.160.230.316044H104incl.426.0568.0142.00.470.190.280.337338.9H104incl.460.0483.023.01.220.450.780.7611443.6H105 18.0445.1427.10.210.110.090.155647.3H105incl.187.0388.6201.60.260.110.140.166754.6H105incl.197.0268.271.20.350.160.180.258445.4H105incl.360.0388.628.60.450.220.240.165253.1H106 18.0462.0444.00.290.190.100.125342H106incl.105.0508.0403.00.310.200.120.135643.1H106incl.105.0372.0267.00.350.260.100.136240.4H106incl.105.0237.0132.00.510.450.090.165637.4H106incl.105.0153.048.01.000.980.120.296432.5H106incl.105.0121.616.62.022.050.190.487532.7H106incl.105.0113.08.03.934.040.340.8912427.4H107 6.8537.0530.20.200.100.090.125440.1H107incl.107.0570.0463.00.210.100.100.125941.2H107incl.107.0537.0430.00.230.110.110.126040.7H107incl.107.0167.060.00.350.310.060.115038.6H107incl.107.0129.222.20.570.540.080.175336.3H107incl.299.0528.0229.00.250.090.160.166442.7H107incl.299.0354.055.00.410.130.260.279547.5H107incl.471.0528.057.00.390.130.250.255949.7H108 15.0150.0135.00.390.350.060.204037.1H108incl.38.0150.0112.00.430.400.070.224238.2H108And501.0576.075.00.250.100.130.256236.9 Notes: 1 - Copper Equivalent (CuEq) currently does not include Scandium2 - The intervals presented in this table are not true widths. The true width of mineralized sections has not been determined.3 - Metal equivalents should not be relied upon for future evaluations. Drill hole intercepts included in this news release are core lengths that may or may not represent true widths of mineralization. It is not possible to determine true widths.4 - Parameters used to calculate Copper Equivalent: Au price (US$/oz): 2365.09; Ag price (US$/oz): 27.43; Cu price (US$/lb): 4.17; Co price (US$/lb): 14.76. Au recovery: 89.0%; Ag recovery: 68.0%; Cu recovery: 84.0%; Co recovery: 78.0%. * Copper Equivalent Calculation CuEq in % = ([Ag grade in ppm] *27.43*0.68/31.1035 + [Au grade in ppm] *2365.09*.89/31.1035 + 0.0001* [Co grade in ppm] *14.76*0.78*22.0462 + 0.0001* [Cu grade in ppm] *4.17*0.84*22.0462)/(4.17*22.0462*0.84).Details of the algorithm used to estimate %CuEq are presented in the notes above. The metal values used in our current algorithm are average trailing three years commodity prices, and do not reflect recent dramatic increases in prices of mineral commodities. Scandium, a high value strategic alloy metal (customarily quoted as Sc2O3 ) that is present in small but highly important amounts in Hat mineralization.Core samples are delivered securely to a fully accredited commercial laboratory and processed by industry-standard methods. Assays are received at irregular intervals, verified by reference to notes provided by our field crew, added to our database, and disseminated publicly by News Release.Figure 1: Plan view showing drill holes H102-H108 relative to the 2026 PEA pit shell and the eastern side of the Hat mineralized system.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_001full.jpgFigure 2: Cross-section through H102-H105 showing mineralized intervals within and below the eastern side of the 2026 PEA pit shell.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_002full.jpgFigure 3: Cross-section through H106-H108 showing the Far East Zone. The section illustrates a mineralized horizon extending more than 250m vertically in this view.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_003full.jpgGeological InterpretationResults from H102-H105 provide additional information on continuity within and below the eastern side of the PEA pit shell. Figure 2 shows reported intervals extending more than 150m below the shell in this section. The new data increase drill coverage in areas relevant to future resource modelling and future assessment of mineral resource classification.Results from H106-H108 identify the Far East Zone approximately 150m east of the existing mineralization envelope. The H106-H108 platform lies approximately 233m from the H102-H105 platform. Figure 3 illustrates the vertical extent of reported mineralization in the Far East Zone section. Additional drilling is required to determine the zone geometry, continuity and relationship to the broader Hat system.H106-H108 are also notable for gold-enriched intervals. H106 returned 48.0m grading 0.98 g/t Au, including 16.6m grading 2.05 g/t Au and 8.0m grading 4.04 g/t Au. H108 returned 112.0m grading 0.40 g/t Au. These results provide geological vectors for follow-up work. The significance of the metal distribution will be assessed through further drilling and modelling.Figure 4: Plan view of the 2026 PEA pit shell showing the East Zone and Far East Zone drill areas.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_004full.jpgFigure 5: Three-dimensional perspective view looking west showing the 2026 PEA pit shell and the eastern 2025 drill areas.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_005full.jpgFigure 6: Three-dimensional view looking west showing 2025 drill intercepts below the 2026 PEA pit shell.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_006full.jpgFigure 7: Three-dimensional view looking north showing eastern drill intercepts relative to the 2026 PEA pit shell.To view an enhanced version of this graphic, please visit:https://images.newsfilecorp.com/files/8003/300676_a6fe9797549ab975_007full.jpgTable 2 summarizes coordinates of the recent drill holes.Table 2: Drill Hole Locations and OrientationsCoordinates are reported in NAD83 / UTM Zone 9N.DDH ID UTM-East (m)UTM-North (m)Elevation (m)Dip (°)Azimuth (°)Max-Depth (m)H1023482036453897972-88.470732H1033482036453897972-67.84135720H1043482036453897972-75.79167702H1053482036453897972-80.7230663H1063484186453987982-89.110651H1073484186453987982-75.51100651H1083484186453987982-75.06170648 Quality Assurance and Quality Control:Hat Project drill cores are processed at Doubleview's field camp where they are photographed, measured and logged by our technical staff and then divided using a diamond bladed saw. One half is placed in a stout bag to form the assay sample that is forwarded securely to the independent analytical lab. The remaining half core is stored on site where it is available for further examination and sampling. The assay cores are subject to a Chain of Custody routine as they are shipped from camp to a bonded carrier for delivery to the lab.All core samples are prepared and analyzed at AGAT Laboratories in Calgary, an independent ISO 17025 and ISO 9001 certified facility. Samples are dried, crushed to 70% passing 2 mm, split to obtain a 250 g representative portion, and pulverized to 85% passing 75 µm. Gold, platinum, and palladium are assayed by 30-50 g fire assay with ICP-OES finish. Multi-element analyses (up to 48 elements) are performed by four-acid digestion with ICP-OES/MS, with ore-grade assays applied where required. Selected samples are further analyzed for whole-rock oxides using lithium borate fusion with ICP-OES, and Loss on Ignition is determined separately. Routine quality assurance protocols include insertion of blanks, duplicates, and certified reference materials, ensuring accuracy and reliability of results.Doubleview maintains a website at www.doubleview.ca.Qualified Persons:Erik Ostensoe, P. Geo., a consulting geologist, and Doubleview's Qualified Person with respect to the Hat Project as defined by National Instrument 43-101 Standards of Disclosure for Mineral Projects, has reviewed, and approved the technical contents of this news release. He is not independent of Doubleview as he is a shareholder in the company.About Doubleview Gold CorpDoubleview Gold Corp. is mineral resource exploration and development company headquartered in Vancouver, British Columbia, Canada. It is publicly traded on the TSX-Venture Exchange (TSXV: DBG), (OTCQB: DBLVF), (WKN: LA1W038), and (FSE: 1D4). Doubleview focuses on identifying, acquiring, and financing precious and base metal exploration projects across North America, with a strong emphasis on British Columbia. The company enhances shareholder value through the acquisition and exploration of high-quality gold, copper, cobalt, scandium, and silver projects-collectively critical minerals utilizing cutting-edge exploration techniques.Doubleview's success is deeply rooted in the unwavering support of its long-term shareholders, supporters, and institutional investors. Their ongoing commitment has been instrumental in advancing the company's strategic initiatives. Doubleview looks forward to further collaborative growth and development and continues to welcome active participation from its valued stakeholders as the company expands its portfolio and strengthens its position in the critical minerals sector.On behalf of the Board of Directors,Farshad Shirvani, President & Chief Executive OfficerFor further information please contact:Doubleview Gold Corp Vancouver, BC Farshad Shirvani President & CEO T: (604) 678-9587 E: corporate@doubleview.caNEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.Forward-Looking InformationCertain of the statements made and information contained herein may constitute "forward-looking information" within the meaning of applicable Canadian securities laws. Forward-looking statements in this news release include, but are not limited to, statements regarding: the interpretation of drill results; the potential extension of mineralization; the identification and significance of the far east mineralized zone; the potential incorporation of drill holes H102 to H108 into future geological models, Mineral Resource Estimates, Preliminary Economic Assessments or other economic studies; the potential for future conversion of Mineral Resources into higher confidence categories; future drilling plans; future exploration programs; the potential economic significance of scandium, cobalt, copper, gold and silver mineralization; and the continued advancement of the Hat Project.Forward-looking statements are based on assumptions that management considers reasonable at the time they are made, including assumptions regarding geological continuity, future exploration results, metallurgical recoveries, metal prices, availability of financing, regulatory approvals, access to the property, and the Company's ability to complete future technical studies. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those projected. Such risks include, but are not limited to: risks associated with mineral exploration and development; uncertainty of geological interpretation; uncertainty of Mineral Resource estimation; volatility in metal prices; metallurgical and processing risks; permitting and environmental risks; title and access risks; financing risks; equipment availability; First Nations consultation and engagement; and other risks disclosed in the Company's public filings.Except as required by applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information, whether as a result of new information, future events or otherwise.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300676 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Jun 9, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines today announced that it has entered into an exclusive licensing agreement with Jiangsu Vcare PharmaTech Co., Ltd. (“Vcare”), for the development, registration and commercialization of Sumecigrel (formerly known as Vicagrel) across the Asia-Pacific region, including Southeast Asia, South Korea, Australia, Hong Kong SAR, Macao SAR, and Taiwan region, China. Pursuant to the agreement, Everest Medicines will pay Vcare PharmaTech an upfront payment of RMB 20 million, along with subsequent milestone payments and commercial supply procurement.This collaboration strengthens the Company’s cardiovascular portfolio and highlights Everest’s continued focus on the Asia-Pacific market, supporting the advancement of its regional strategy and the development of innovative therapies.Sumecigrel is an antiplatelet agent and a new-generation oral P2Y12 receptor antagonist. It is being clinically developed for the treatment and prevention of atherothrombotic events such as acute coronary syndrome (ACS), ischemic stroke (IS) and peripheral arterial disease (PAD). As a novel antithrombotic drug self-developed by Vcare PharmaTech, the product is currently advancing preparations for NDA in China, the United States, Europe.The molecular design of Sumecigrel targets the black box warning associated with clopidogrel resistance. It innovatively optimizes the metabolic pathway of clopidogrel while retaining its active metabolite, striking a better balance between therapeutic benefits and bleeding risks inherent to antiplatelet medications. Featuring faster onset of action, lower dosage, more stable efficacy, better controllable bleeding risks, reduced metabolic burden and broader clinical applicability, Sumecigrel is a novel antiplatelet candidate with prominent Best-in-Class potential. It is expected to address the increasingly personalized demands for antithrombotic therapy and become a blockbuster product in the antithrombotic market.Cardio-cerebrovascular diseases rank among the leading causes of death worldwide. Related fatalities rose sharply to 17.9 million in 2019, accounting for approximately 32% of all global deaths. Around 85% of these deaths were attributed to myocardial infarction (a major type of ACS) and stroke. The death toll from cardio-cerebrovascular diseases further climbed to 19.2 million in 2023.Antiplatelet drugs inhibit platelet activation, adhesion and aggregation to reduce thrombotic risks, and are widely used for the prevention and treatment of atherothrombotic diseases. P2Y12 receptor antagonists are a major category of mainstream antiplatelet medications. Currently marketed products in this class continue to face challenges in balancing variability in efficacy and bleeding risk across patients, and optimizing the overall clinical benefit–risk profile remains an important unmet medical need in this therapeutic area.“This collaboration with Vcare PharmaTech marks another step in strengthening our presence in the Asia-Pacific region,” said Mr. Yifang Wu, Chairman of the Board of Everest Medicines. “Sumecigrel is a next-generation oral P2Y12 receptor antagonist with Best-in-Class potential, offering differentiated clinical benefits and complementing Everest’s cardiovascular pipeline. Leveraging our clinical, regulatory, and commercial capabilities across the Asia-Pacific as a global platform for innovative therapies, Everest will drive Sumecigrel’s development and commercialization to realize its full clinical and commercial value and bring new treatment options to more patients.”"As our novel antithrombotic drug, Sumecigrel represents our first innovative pharmaceutical product, "said Dr. Gong Yanchun, Co-founder, Chairman and CEO of Vcare PharmaTech. "This strategic partnership with Everest Medicines serves as the first step of Sumecigrel’s global commercialization strategy, creating a win-win situation for an original innovation enterprise and an international commercial platform. Powered by AI-driven differentiated original design, Vcare PharmaTech consistently focuses on the development of innovative drugs and leading therapies, standing as a pioneer of the next-generation original innovation in the global antiplatelet field. We will accelerate the global R&D and registration progress of Sumecigrel, consolidate its global competitive edges, and contribute Chinese innovation to the diagnosis and treatment of cardiovascular diseases across the Asia-Pacific and the world at large."As a next-generation P2Y12 receptor antagonist, Sumecigrel has completed Phase I, Phase II, China-US PK/PD bridging study and Phase III clinical trials. It has demonstrated favorable efficacy and safety with solid clinical value, and is poised to become an improved treatment option for patients with ACS, IS and PAD.Of note, the addition of Sumecigrel further enriches Everest Medicines’ cardiovascular portfolio. As the Company continues to expand its presence in the CKM (cardiovascular, kidney and metabolic) disease space, Sumecigrel is expected to strengthen its cardiovascular product portfolio and generate synergies with existing products and pipeline assets, further deepening the Company’s presence in related therapeutic areas.From a strategic perspective, this collaboration represents another important step in Everest Medicines’ ongoing efforts to deepen its presence across the Asia-Pacific region. Notably, the Company has continued to advance strategic partnerships and resource integration across the region. Through its collaboration with Mabworks, Everest secured the commercialization rights to Bejescin®, a third-generation anti-CD20 therapy, in multiple Asia-Pacific markets, further strengthening its portfolio in nephrology and autoimmune diseases. Industry observers believe that the licensing of Sumecigrel reflects Everest Medicines’ continued commitment to the Asia-Pacific market and its strategy of accelerating the regional development and commercialization of innovative therapies. As its regional product portfolio and operating capabilities continue to expand, Everest Medicines is well positioned to further leverage its integrated biopharmaceutical platform and accelerate the value realization of innovative therapies across the Asia-Pacific region. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHANGHAI, Jun 9, 2026 - (ACN Newswire via SeaPRwire.com) - Hua Medicine ("the Company", stock code: 2552.HK) presented a series of breakthrough research findings on dorzagliatin (Trade name: HuaTangNing, Trade name in Hong Kong: MYHOMSIS(R)), the world’s first-in-class glucokinase activator (GKA), at the 86th Scientific Sessions of the American Diabetes Association (ADA). Through oral and poster presentations that demonstrated the breadth and depth of its science, the Company showcased data from its Metabolic Homeostasis Technology Platform, spanning combination therapies, large-scale real-world outcomes, AI-powered precision medicine, and personalized care tools.Collectively, the presentations continued to demonstrate the significance of dorzagliatin’s mechanism of action – restoring glucose homeostasis at its root cause – and its therapeutic potential across a spectrum of complex metabolic diseases including Type 2 diabetes (T2D), Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), obesity, and Maturity-Onset Diabetes of the Young Type 2 (MODY2).The new research findings strengthen Hua Medicine’s position as a global leader in glucose homeostasis research.I. Leveraging Metabolic Homeostasis Platform to Expand Therapeutic Landscape for Metabolic DiseasesDorzagliatin targets glucokinase (GK), the body’s fundamental glucose sensor, by repairing impaired GK function and expression in patients with Type 2 diabetes to enhance glucose sensitivity. Through coordinated multi-organ regulation across the pancreas, liver, and intestines, dorzagliatin fundamentally restores glucose homeostasis and addresses a broad spectrum of metabolic disorders.Building on this unique mechanism, Hua Medicine presented three combination therapy studies in animal models of metabolic disorder at ADA 2026. The data demonstrate that dorzagliatin acts synergistically with oral small molecule GLP-1 receptor agonists, THR-β agonists, and pan-PPAR agonists. It delivers benefits well beyond glycemic control, including weight reduction, lipid modulation, uric acid reduction, and improved insulin sensitivity.In an oral presentation, Hua Medicine reported preclinical findings evaluating dorzagliatin in combination with the oral small molecule GLP-1 receptor agonist orforglipron. In a significant scientific first, this study demonstrated synergies between a GKA and a small molecule GLP-1RA in animal models, providing a mechanistic and clinical rationale for an oral combination regime that pairs homeostasis restoration with incretin activation. Taken together, the dose-sparing effect, where low-dose combinations achieved comparable efficacy to high-dose monotherapy, addresses one of the most common barriers to GLP-1RA adherence in clinical practice: gastrointestinal tolerability.The study used diet-induced obese (DIO) human GLP-1R transgenic mice, which recapitulate human obesity-associated Type 2 diabetes. The 4-week once-daily oral treatment systematically evaluated monotherapy and combination therapy across key efficacy and safety parameters, including glycemic control, insulin secretion, body weight and lipid profiles.In this model, dorzagliatin repairs GK function across the pancreas, liver, and intestines to restore glucose homeostasis, enhance glucose-stimulated insulin secretion (GSIS), and promote endogenous GLP-1 secretion.Orforglipron directly activates GLP-1 receptors to induce robust weight loss, glycemic control, and lipid improvement; although it also carries the risk of adverse gastrointestinal (GI) events.Synergistic Glycemic Control: Combination therapy produced superior glucose-lowering effects versus monotherapy and enabled dose sparing potential, with low-dose combinations achieving efficacy comparable to high-dose monotherapy. Orforglipron amplified dorzagliatin-mediated improvements in β-cell function and hepatic glucose metabolism.Enhanced β-Cell Function: Dorzagliatin improves the β-cell function of DIO mice, and combined treatment synergistically boosted insulin secretion and sensitivity for better glycemic control and β-cell protection.Preserved Weight and Lipid Benefits: The combination fully retained orforglipron-induced weight reduction and lipid-lowering effects.Favorable Safety and Tolerability: The combination was well tolerated with no new safety signals. Dose sparing markedly reduced common GLP-1RA-related GI side effects such as nausea and vomiting, improving long-term adherence.Together, these complementary mechanisms across glycemic control, weight loss, and lipid improvement, position the potential combination as a highly effective, well-tolerated, and differentiated oral option for T2D patients with obesity. Hua Medicine plans to advance clinical studies to evaluate efficacy, safety, optimal dosing, and target patient populations most likely to benefit.Hua Medicine also presented the findings of two additional combination therapy studies in poster presentations:1.Dorzagliatin + Resmetirom (THR-β Agonist): In DIO mice with MASLD, the combination synergistically improved systemic metabolism and exerted hepatoprotective effects, optimizing glycemic control, regulating lipids, reducing uric acid, and alleviating hepatic fibrosis. This supports the clinical potential of dorzagliatin for T2D patients with MASLD.2.Dorzagliatin + Chiglitazar (Pan-PPAR Agonist): The combination of dorzagliatin and the pan-PPAR agonist chiglitazar demonstrates significant synergistic metabolic benefits in DIO mice model of MASLD. The glucose-lowering effect is superior to monotherapy. At the same time, it optimizes basal glucose metabolism and improves glucose disposal following glucose challenge. Compared with monotherapy, this combination regimen more effectively improves glucose tolerance, reduces insulin resistance, enhances insulin sensitivity and β-cell function, and elevates high-density lipoprotein cholesterol levels in mice. These findings underscore the potential of this combination to address metabolic dysregulation in MASLD and provide important preclinical support for subsequent clinical research to explore its therapeutic value in the metabolic and liver diseases.Together, these studies demonstrate that dorzagliatin’s core mechanism of restoring metabolic homeostasis operates synergistically with multiple targeted agents, supporting its therapeutic potential in obesity, MASLD, and other metabolic disorders.II. Large-Scale Post-Marketing Real-World Study (BLOOM) Validates Long-Term Efficacy and SafetyAt ADA 2026, Hua Medicine presented further key results from the BLOOM study, a large-scale post-marketing real-world investigation of dorzagliatin in routine clinical settings.BLOOM aims to evaluate the long-term safety and effectiveness of dorzagliatin in a broad, clinically diverse population of people with Type 2 diabetes. The BLOOM study enrolled 2,024 patients with Type 2 diabetes across 80 clinical centers in China (62% male; mean age 55.5 years; mean BMI 25.1 kg/m²; mean diabetes duration 7.9 years; baseline HbA1c 7.8%) with dorzagliatin treatment and follow-up lasting up to 52 weeks. It evaluated long-term safety and effectiveness of dorzagliatin as monotherapy or in combination with other anti-diabetic agents in real clinical settings, including elderly patients, people with renal impairment, and those on complex multiple-drug regimens including insulin. The study results demonstrated that:During the 52-week treatment period, no drug-related serious adverse events (SAEs) or severe hypoglycemia were reported over 52 weeks. Clinically meaningful hypoglycemia remained

KOSICE, SLOVAKIA, June 9, 2026 - (ACN Newswire via SeaPRwire.com) - The original film by Vlado Zelezňák Jr. has achieved remarkable international success. The new Slovak-Japanese animated sci-fi film Angel & Meow celebrated its World Premiere by winning the prestigious Crystal Pine Award. The film proved its quality against an immense global competition of nearly 1,000 entries from 81 countries. This achievement is particularly notable as the film was produced as a fully independent project by the Slovak company GONG Art Company, led by Vlado Zelezňák Sr.The success took place at the 14th International Sound & Film Music Festival (ISFMF) in Varazdin, Croatia, which ranks among the world’s three most significant festivals dedicated to film music and sound. The gala ceremony was held in the magnificent historic setting of the Croatian National Theatre (HNK Varazdin).In the Company of Oscar Winners and Hollywood Stars The winners were selected by a prestigious international jury consisting of elite professionals—recipients and nominees of Oscar, Emmy, BAFTA, Grammy, and César awards. The jury president for this year was the legendary and respected actor Ciarán Hinds. Widely considered one of the most acclaimed actors of his generation, Hinds is known to audiences for global blockbusters such as Game of Thrones, Harry Potter and the Deathly Hallows, the Oscar-winning drama Belfast, and the animated phenomenon Frozen.Slovak creators stood on stage alongside the world’s absolute elite. Other award-winning personalities at this year’s festival included Hollywood actor Simon Pegg (Mission: Impossible, Star Trek), who received a Lifetime Achievement Award, and Oscar-winning sound designer James Mather (Top Gun: Maverick). The Slovak team shared the spotlight with elite sound professionals from the film Sirât, including Yasmina Praderas (Goya winner and Oscar nominee) and Laia Casanovas (European Film Award and Goya winner).Personal Moments from the Festival Stage The heart and engine of the project is Slovak producer, screenwriter, composer, and sound designer Vlado Zelezňák Jr., who accepted the award directly from the festival directors. During the gala, he experienced unforgettable personal encounters with the world’s biggest film stars."When we stood on stage after the announcement, I expressed my appreciation to the jury president, Ciarán Hinds, for his work. I was delighted that he already recognized our film—he responded immediately with a wide smile by singing the title of our project. It was a pleasant and spontaneous experience," recalls Vlado Zelezňák Jr.The meeting with Hollywood actor Simon Pegg was equally emotional. "I spoke with Simon on the day of the World Premiere, where I had the opportunity to introduce our film to him personally. When we met again on stage the next day during the awards ceremony, it was great to see that he was familiar with Angel & Meowand congratulated me with a smile again. These moments are a huge encouragement for my future work," adds the Slovak creator.The entire event was managed by the festival founders. The gala was hosted by Artistic Director Ozren K. Glaser, who publicly congratulated Vlado Zelezňák Jr. on stage, while Executive Director Marijana Glaser ceremoniously presented the Crystal Pine Award. "Our huge thanks go to the three main organizers from the Glaser family—Marijana, Ozren, and producer Zeljko Glaser. I would like to express my appreciation for their excellent, professional organization and for building a festival of a truly Hollywood standard, where one felt like they were at the Oscars from the very first moment," concludes Vlado Zelezňák Jr.A World Premiere of Visual Poetry Before an Elite Audience The World Premiere of Angel & Meow, held on May 22 at CineStar Varazdin, played to a fully packed theater. The audience consisted of an elite group of nominated composers, sound designers, and filmmakers from around the world. The premiere was attended in person by living legends of the film industry, such as Oscar-winning sound mixer Mark Ulano (Titanic, Inglourious Basterds), as well as singer and producer Kathy Kelly from the legendary group The Kelly Family.In addition to high-quality animation and visuals, the international jury praised the film’s powerful sound design, original score, and the overall story, all created by Vlado Zelezňák Jr. The visual and animation components were crafted by a top-tier Japanese team in Tokyo, led by director and lead animator Clemhyn Escosora from Adarnia studio (a subsidiary of Fuji Corp.).Global Sound Design and a Soundtrack as a Narrator Since the story relies on the pure power of image and sound, the meticulously designed sound and film music step into the spotlight, taking on the role of the primary narrator alongside the animation. The resulting soundtrack is exceptionally rich, varied, and intense."The sound design was created all over the world. While atmospheric sounds were recorded directly on the streets and coast of Cannes, the orchestral and electronic music was composed in studios in Slovakia. To achieve absolute authenticity, we recorded live animals and constantly experimented with sound," explains Vlado Zelezňák Jr. Over the 15-minute runtime, the viewer experiences diverse musical landscapes—from massive orchestral passages and intimate piano and guitar moments to pure sci-fi sounds of analog Moog synthesizers and wind instruments.Sound in the Hands of a Living Legend The final sound mastering was handled in the USA by an absolute legend in the field—Vlado Meller, in his prestigious American studio. Throughout his rich career, he has collaborated with icons such as Céline Dion, Andrea Bocelli, and the Red Hot Chili Peppers. Meller recently exclusively finished Dolby Atmos mastering for Michael Jackson’s legendary albums for Sony USA, released in conjunction with the recently unveiled biographical film hit Michael.Angel & Meow has shown from the very start that independent Slovak production from the GONG Art Company workshop, combined with an original script, film music, and sound design, can successfully stand its ground on the international stage against the world's biggest productions.About GONG Art Company30 Years of Creativity and Innovation GONG Art Company is an established pillar of the Slovak audiovisual scene with a nearly 30-year history. The company is renowned for its long-standing technological and creative co-production work with Slovak National Television and Radio, providing comprehensive music production for iconic projects such as Hviezdička and Zlatá brána. The company has been awarded multiple Gold and Platinum records for its music production and children's audio titles.Today, GONG operates as a modern production house focused on international film co-productions. The company manages its own film projects, with in-house recording studios dedicated to film scoring and sound design. This infrastructure allows for simultaneous production across multiple works—while the soundtrack for Angel & Meow was being composed in one studio, another was handling sound post-production for the documentary Man from the Mountain, which is also heading to international film festivals this year.GONG is also the founder of the global platform FMC (Film Music Contest & Festival), which connects elites from Hollywood and Netflix with global talent. The team regularly participates in key industry markets such as Cannes (Marché du Film), Annecy (MIFA), and Berlinale (EFM), building on a tradition of high-quality original work with the ambition to succeed in the global market.More information: www.angelandmeow.com Media Contact: Mgr. Vlado Zelezňák JR. Phone: +421 911 789 888 Email: press@angelandmeow.com Facebook: https://www.facebook.com/angelandmeowmovie/ Instagram: https://www.instagram.com/angelandmeowmovie/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SAN DIEGO, June 9, 2026 - (ACN Newswire via SeaPRwire.com) - General Atomics Aeronautical Systems, Inc. (GA‑ASI) is deepening its footprint in the Dutch innovation ecosystem, with new investments in six Netherlands-based technology companies through its Blue Magic Netherlands (BMN) venturing initiative.These new partnerships follow the latest BMN event in Eindhoven, a fast-paced, "shark tank"-style forum in which Dutch startups and scaleups pitched breakthrough technologies directly to GA‑ASI decision makers. The most recent edition drew more than 350 attendees from across the country's aerospace, defense, and high-tech communities.Building on the success of prior events, GA‑ASI has selected six Dutch companies for new investment and collaboration. GA-ASI also is increasing its investment in Emergent Swarm, first discovered at BMN 2024. Emergent Swarm is partnering with GA‑ASI to further mature its swarming autonomy detection capability."Blue Magic Netherlands is our window into the Dutch innovation ecosystem," said Brad Lunn, Managing Director, GA‑ASI. "We are not just scouting ideas. We are deploying capital, engineering resources, and access to platforms to help these companies scale. We're making these new investments because it is clear to us that the Netherlands is one of the most dynamic technology hubs in Europe."The six new GA‑ASI portfolio companies are:OPT/NET B.V. - GA-ASI, alongside its GA-Intelligence affiliate, will be working with OPT/NET to explore collaboration opportunities for a variety of AI-related missions, including drone swarm management and dark vessel detection.Vaeridion B.V. - GA-ASI will be working with Vaeridion to evaluate their advanced battery pack technology for use in current and future GA-ASI platforms.Touchwaves B.V. - GA-ASI will be evaluating Touchwaves' haptic technology for use in remotely piloted UAS environments to determine the potential benefits to long-duration missions and aircrew information overload.FDCL Defence B.V. - GA-ASI and GA-Intelligence will be working with Fiducial to explore the effectiveness of the company's technology toward massively scaled low-cost future platforms.Vydar Commercial B.V. - GA-ASI will evaluate Vydar's technology in a variety of relevant GPS-denied environments and GA-ASI and GA-EMS platforms.Emproof B.V. - GA-ASI will evaluate the effectiveness of Emproof's data protection technology for applicability to current and future GA-ASI platforms.GA‑ASI expects to announce additional investments from the 2025 BMN cohort in the coming months, as technical evaluations and co‑development discussions progress.About Blue Magic VenturesBlue Magic Ventures is GA‑ASI's corporate venturing initiative, designed to identify, invest in, and scale breakthrough technologies from startups and innovators around the world. Through capital investment, access to platforms, and deep technical collaboration, Blue Magic Ventures accelerates the path from concept to capability for dual‑use technologies.About GA-ASIGeneral Atomics Aeronautical Systems, Inc., is the world's foremost builder of Unmanned Aircraft Systems (UAS). Logging more than 9 million flight hours, the Predator® line of UAS has flown for over 30 years and includes MQ-9A Reaper®, MQ-1C Gray Eagle®, MQ-20 Avenger®, and MQ-9B SkyGuardian®/SeaGuardian®. The company is dedicated to providing long-endurance, multi-mission solutions that deliver persistent situational awareness and rapid strike.For more information, visit www.ga-asi.com.Avenger, EagleEye, Gray Eagle, Lynx, Predator, Reaper, SeaGuardian, and SkyGuardian are trademarks of General Atomics Aeronautical Systems, Inc., registered in the United States and/or other countries.GA-ASI Media RelationsGeneral Atomics Aeronautical Systems, Inc.ASI-MediaRelations@ga-asi.com(858) 524-8101SOURCE: General Atomics Aeronautical Systems, Inc. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HO CHI MINH / SEOUL, June 8, 2026 - (ACN Newswire via SeaPRwire.com) - Global content-tech company TON Corporation (CEO Henry Kim) today announced that it will officially launch 'TonTV', its Telegram-native short-drama platform, worldwide in September 2026. TonTV lets the ~1 billion people who use Telegram each month instantly and freely watch short dramas with a single Telegram account — with no separate app install and no complicated sign-up.Short drama is one of entertainment's fastest-rising categoriesShort-form drama has moved to the center of global media consumption. Global in-app revenue for short dramas reached $2.98 billion in 2025, up 115% year over year, and in Q4 2025 short-form titles overtook long-form streaming apps in downloads for the first time (733M vs. 658M), according to Sensor Tower and Omdia. With short runtimes, high completion rates, and mobile-first immersion, the format is growing fastest among younger viewers. TonTV places dramas of around two minutes at the heart of this trend — short but intense chapters that build a "can't-stop-once-you-start" experience.The Telegram Mini App: tearing down the barrier to entryTonTV's core strength is that it runs atop Telegram, a massive global platform. Existing OTT services require a long entry sequence — app-store search → download → install → sign-up → enter payment details. TonTV removes it: open the Mini App inside Telegram → watch instantly, for free.The user reach that global OTT leaders such as Netflix and Disney+ built over years and at enormous cost is something TonTV can address from day one, across Telegram's ~1 billion monthly users. This dramatically lowers user-acquisition cost while driving early growth through natural word-of-mouth across Telegram's groups and channels.Three years of preparation, and "why we can win"TonTV did not appear overnight. Over the past three years, TON Corporation has focused on platform-technology development, global content partnerships, and a local-operations model in preparation for launch.CTO Tony cited the following reasons TonTV can be a market "game changer" rather than a late follower:Frictionless reach — among the first specialized short-drama platforms to reach Telegram's ~1 billion monthly users, free, in one clickFree entry — anyone can start at no cost, a strong advantage for early user acquisitionNetwork effects — discussion, sharing, and recommendation happen at the same moment as viewingViewer-participation rewards — enjoying content itself returns benefits and rewards, building loyaltySimultaneous global release — worldwide at once, with no region-by-region app-store approvalOn these strengths, TonTV aims to grow beyond short drama into real-time formats such as live streaming over time.A 'new stage' for producers, actors, and staff worldwideTonTV goes beyond a viewing platform to open opportunity for the global content industry. Producers can showcase work directly to a global audience; actors and staff can widen their stage across borders. For emerging teams and new actors who have struggled to get a chance at traditional broadcasters or large OTTs, TonTV offers an open stage judged on ability — creating jobs across planning, production, acting, and post-production."Global one platform, local content"TonTV places local subsidiaries in major markets — Korea, Japan, Vietnam, India, Indonesia, and the Philippines — planning and producing content suited to each region's culture on the ground. Combining a global platform's scale with local content's intimacy, TonTV aims to be a true global OTT where anyone can enjoy "stories from home." The local-subsidiary model expands content and markets quickly while keeping head-office cost low.A dual revenue model: "growth and profit together"TonTV operates a dual model: a free, ad-supported tier where all users watch at no cost, and a premium subscription for an ad-free experience. Advertiser acquisition and content production through local subsidiaries create a cycle in which ad and subscription revenue grow with the user base. Telegram's low acquisition cost and short-form's high completion rates support this model.Comment from TON Corporation CTO TonyCTO Tony said: "For the past three years we've focused everything on creating the easiest, most enjoyable way to watch drama. On Telegram — a playground of a billion people — TonTV sets a new standard for short drama anyone can enjoy free, with a single account."He added: "TonTV will create the best experience for viewers, a new stage for creators, and new jobs for the industry — and our ambition is to become the global leader in short-drama and live content."Future plansFrom its September 2026 launch, TonTV plans to rapidly expand its content lineup and service regions, broaden from short drama into real-time formats such as live streaming, and accelerate global expansion through its local subsidiaries.About TON CorporationTON Corporation is a global content-tech company headquartered in Ho Chi Minh, Vietnam. Through TonTV, its Telegram-native short-drama platform, it aims to deliver a new entertainment experience to users worldwide and open opportunity for global content creators.Media ContactBrand: TON CorporationContact: PR TeamWebsite: https://tontv.toncorp.ioTelegram: https://t.me/TontvOfficialChannel Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHENZHEN, CHINA, June 8, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that the preclinical results of its self-developed innovative INHBE-targeting small nucleic acid drug CMS-D008 injection ("CMS-D008"), have been presented in a poster at the American Diabetes Association (ADA) 86th Scientific Sessions (June 5-8, 2026, New Orleans, USA). As the world's largest and most authoritative annual scientific meeting in the fields of diabetes and metabolic diseases, it convened over 12,000 leading clinicians, researchers, and healthcare professionals worldwide to explore cutting-edge advances in diagnostics, therapies, and technologies.About CMS-D008CMS-D008 is a self-developed novel siRNA therapy administered by subcutaneous injection. It targets and reduces the hepatic expression of the inhibin subunit beta E (INHBE) gene and lowers the level of INHBE-encoded Activin E protein, which blocks Activin E-ALK7 signaling and reduces fat accumulation effectively. It demonstrates the potential for high-quality, long-term weight loss that boosts fat-specific loss while preserving muscle mass. Currently, the Phase I clinical trial of CMS-D008 in healthy subjects is progressing steadily. In the future, it may be developed for the treatment of abdominal obesity and related metabolic diseases.CMS-D008 has demonstrated encouraging preclinical data. The preclinical research results of CMS-D008 presented at the ADA Scientific Sessions showed that in obese animal models, CMS-D008 efficiently and sustainably suppressed INHBE expression, achieving significant weight loss and fat reduction while sparing muscle mass, with a favorable safety profile, indicating the potential for healthy weight loss. Details are as follows:Title: CMS-D008 specifically silences INHBE mRNA, delivering fat-selective weight loss in preclinical studyPresentation Number: 3079-LBPresentation format: PosterDate/Time: June 7, 2026 01:30 PM - 02:30 PM (Local Time)Location: Hall D-EResults:In a high-fat diet-induced model of humanized INHBE obese mouse (hINHBE DIO mouse), CMS-D008 significantly reduced hepatic INHBE mRNA expression and serum Activin E protein levels, leading to marked decreases in body weight, total body fat, and regional fat mass while preserving lean mass.In a model of obese cynomolgus macaque, CMS-D008 also significantly reduced hepatic INHBE mRNA expression and plasma Activin E protein levels, and effectively suppressed weight gain induced by a sustained high-fat diet.The inclusion of these findings at the ADA Scientific Sessions reflects the international academic community's interest in the scientific value and clinical potential of CMS-D008 in the field of obesity/metabolic treatment. CMS-D008 will synergize with CMS-D005, a self-developed, clinical-stage innovative drug (a GLP-1R/GCGR dual agonist), to deliver highly effective weight-loss benefits and long-term maintenance of results, providing patients with a more comprehensive and innovative treatment option.CMS is committed to in-house R&D as a core driver of its long-term growth and continues to advance innovation in cutting-edge therapeutic areas. Currently, 6 self-developed products with global rights, including CMS-D008, have entered the clinical stage, with over 20 additional self-developed projects steadily progressing in preclinical research. Looking ahead, the Group will continue to focus on unmet medical needs, efficiently advance product R&D and commercialization, and bring more comprehensive and innovative therapies to benefit broad patient population.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the cardiovascular-kidney-metabolic/gastroenterology/ophthalmology/skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Jun 8, 2026 - (ACN Newswire via SeaPRwire.com) - Everest Medicines (HKEX 1952.HK) announced that it has entered into an Asset Purchase Agreement with Corxel Pharmaceuticals (“CORXEL”). Under the agreement, Everest has acquired the rights to develop, manufacture, and commercialize LNZ100 (1.44% aceclidine, U.S. brand name VIZZ) in Greater China, including Chinese mainland, Hong Kong SAR, Macao SAR, and Taiwan region. Everest will pay an upfront payment and potential development milestone payments. As part of this agreement, Everest will be assigned and transferred the rights and obligations under the LENZ License Agreement entered into by CORXEL in April 2022 and certain related ancillary agreements. This transaction is expected to further expand the Company’s innovative product portfolio, strengthen its presence in ophthalmology, and enhance overall strategic synergies across its business.LNZ100 is a once-daily prescription eye drop indicated for the treatment of presbyopia. Its active ingredient, aceclidine, is a small molecule acetylcholine receptor agonist that causes pupil contraction, or miosis, creating a pinhole effect that improves near vision. Studies have shown that aceclidine's mechanism of action (MOA) is well positioned to create a pinhole pupil effect while avoiding the impairment of distance vision called myopic shift. Aceclidine's unique pupil selective MOA, in which miosis is decoupled from myopic shift, is expected to allow it to target a broad patient population.According to publicly available information, LNZ100 received approval in the United States in July 2025 and was commercially launched in October of the same year. In China, the New Drug Application (NDA) for LNZ100 was submitted in September 2025, with approval expected in the first quarter of 2027. The therapy has the potential to address a significant unmet medical need in China and position itself as a best-in-class, non-invasive treatment option for presbyopia.“The acquisition of LNZ100 represents an important step in advancing Everest’s strategic focus in ophthalmology. LNZ100 is a differentiated asset with meaningful clinical value and strong commercial potential in the treatment of presbyopia,” said Yifang Wu, Chairman of the Board of Everest Medicines. “As the presbyopia patient population continues to grow, significant unmet needs remain in non-invasive treatment options. We believe LNZ100 has the potential to offer patients a novel, non-invasive therapeutic option and to further broaden the landscape of innovative ophthalmic treatments. The product has already been approved in the United States and is currently under regulatory review in China. We will continue to advance its development and commercialization to make this therapy accessible to presbyopia patients.”Ms. Sandy Mou, Board Executive Director and Chief Executive Officer of CORXEL, said: “We are confident that Everest Medicines’ strong commercialization capabilities will accelerate LNZ100’s market access and bring this innovative treatment to more presbyopia patients in China. Following this transaction, CORXEL’s pipeline will be entirely focused on cardiometabolic therapies. The proceeds from the transaction will enable CORXEL to accelerate the global clinical development of its innovative cardiometabolic pipeline.”Presbyopia is a physiological phenomenon associated with aging that results in a progressively worsening ability to see nearby objects clearly. It is caused by the gradual hardening of the lens. This results in a decline of the eye’s adjustment function, and the inability to focus the image of nearby objects on the retina, leading to a decline in near vision. Studies have shown that the onset of presbyopia typically occurs around the age of 38, reaching a prevalence rate of nearly 100 percent at the age of 52 in China. Currently, the treatment options for presbyopia are very limited. Wearing glasses requires frequent removal and insertion, causing many inconveniences in work and life. Surgery, as an irreversible and invasive operation, has very limited acceptance. There are no approved drugs for the treatment of presbyopia in China and the medical need for non-invasive, safe, efficient and reversible treatments for presbyopia remains unsolved.The NDA acceptance of LNZ100 by the National Medical Products Administration (NMPA) of the People’s Republic of China is based on the data from China Phase 3 Trial. The study was a Phase 3, multicenter, randomized, double-blind, vehicle-controlled study, including a 4-week efficacy study followed by a 6-month extension safety study, designed to evaluate the efficacy and safety of LNZ100 (an aceclidine-based ophthalmic solution) in participants with presbyopia. The objectives were to assess the potential of LNZ100 to improve near vision among Chinese presbyopia patients and to evaluate the efficacy and safety profiles. The trial has enrolled 300 participants.The results showed that LNZ100 achieved the primary endpoint and key secondary endpoints, with statistically significant three-lines or greater improvement in Best Corrected Distance Visual Acuity (BCDVA) at near, and maintaining their optimal distance visual acuity (i.e., not losing 5 or more letters). Results also showed (all p

OTTAWA, ON, June 8, 2026 - (ACN Newswire via SeaPRwire.com) - Focus Graphite Inc. (TSXV: FMS) (OTCQB: FCSMF) (FSE: FKC0) ("Focus" or the "Company") a Canadian developer of high-grade flake graphite deposits and advanced graphite materials for battery, defence, and industrial applications, is pleased to announce the completion of the. Air Quality Assessment ("AQA" or the "Study") for its 100%-owned Lac Knife Graphite Project (the "Project") located in northeastern Quebec.The Study was completed by WSP Canada Inc. ("WSP"), one of the world's leading engineering and environmental consulting firms, under the supervision and management of IOS Geosciences Inc. ("IOS"), as part of the environmental studies supporting the advancement of Lac Knife toward future permitting and development.The AQA evaluated emissions associated with the proposed open pit mine, processing facility, tailings storage facility, stockpiles, haul roads, crushing operations, and supporting infrastructure under conservative maximum operating scenarios. Atmospheric dispersion modelling using Aeromod software, was completed in accordance with the requirements of Quebec's Reglement sur l'assainissement de l'atmosphere ("RAA") and applicable guidance from the Ministere de l'Environnement, de la Lutte contre les changements climatiques, de la Faune et des Parcs ("MELCCFP").According to WSP's conclusions, the modelling results demonstrate that predicted contaminant concentrations remain in compliance with applicable Quebec ambient air quality standards and criteria under the assessed operating conditions. WSP further concluded that all evaluated contaminants met applicable regulatory thresholds. The Study also noted that prevailing winds are predominantly directed toward the south-southeast, away from nearby public infrastructure, residences, and seasonal fishing cabins."Environmental permitting is one of the most important value-creation stages in the development of any critical mineral project," said Dean Hanisch, CEO of Focus Graphite. "The completion of the Air Quality Assessment represents another key component of the broader environmental review process and brings us closer to completing the environmental studies required to support future permitting activities. As these workstreams are completed, Lac Knife continues to become increasingly de-risked from both a technical and environmental perspective while strengthening its position as a strategic North American graphite asset."The Study evaluated a broad range of potential emissions, including particulate matter, nitrogen oxides, sulphur dioxide, carbon monoxide, crystalline silica, and various metals, using a detailed atmospheric dispersion model of the Project area and surrounding receptors based on five years of regional meteorological data.Advancing Toward Environmental Assessment CompletionThe AQA forms part of the broader environmental and permitting work program being advanced at Lac Knife and represents another important milestone toward completion of the environmental and social impact assessment ("ESIA") process. With this Study now complete, the Company is advancing the remaining key environmental workstreams, including the hydrogeological assessment and dam breach analysis, which are expected to further support permitting activities and future project development.The completion of the AQA builds on a series of technical, environmental and infrastructure achievements that continue to de-risk the Project and strengthen Lac Knife's position as a strategically important North American graphite asset. As demand for secure and reliable graphite supply continues to grow, Focus remains focused on advancing the Project through the key milestones required for future development.Qualified PersonThe technical content disclosed in this news release was reviewed and approved by Rejean Girard, P.Geo. (QC), President of IOS Geosciences Inc., a consultant to the Company, and a qualified person as defined under National Instrument NI-43-101.About Focus Graphite Advanced Materials Inc. Focus Graphite Advanced Materials is redefining the future of critical minerals with two 100% owned world-class graphite projects and cutting-edge battery technology. Our flagship Lac Knife project stands as one of the most advanced high-purity graphite deposits in North America, with a fully completed feasibility study. Lac Knife is set to become a key supplier for the battery, defense, and advanced materials industries.Our Lac Tetepisca project further strengthens our portfolio, with the potential to be one of the largest and highest-purity and grade graphite deposits in North America. At Focus, we go beyond mining - we are pioneering environmentally sustainable processing solutions and innovative battery technologies, including our patent-pending silicon-enhanced spheroidized graphite, designed to enhance battery performance and efficiency.Our commitment to innovation ensures a chemical-free, eco-friendly supply chain from mine to market. Collaboration is at the core of our vision. We actively partner with industry leaders, research institutions, and government agencies to accelerate the commercialization of next-generation graphite materials. As a North American company, we are dedicated to securing a resilient, locally sourced supply of critical minerals — reducing dependence on foreign-controlled markets and driving the transition to a sustainable future.For more information on Focus Graphite Inc., please visit http://www.focusgraphite.com.LinkedIn: https://www.linkedin.com/company/focus-graphite/X: https://x.com/focusgraphiteInvestors Contact: Dean Hanisch CEO, Focus Graphite Inc. dhanisch@focusgraphite.com +1 (613) 612-6060Jason LatkowcerVP Corporate Developmentjlatkowcer@focusgraphite.comCautionary Note Regarding Forward-Looking StatementsCertain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words "could," "intend," "expect," "believe," "will," "projected," "estimated," and similar expressions, as well as statements relating to matters that are not historical facts, are intended to identify forward-looking information and are based on the Company's current beliefs or assumptions as to the outcome and timing of such future events.In particular, this press release contains forward-looking information regarding, among other things: the advancement of the Lac Knife Graphite Project toward permitting readiness and future development; the completion and timing of the remaining environmental studies required to support the environmental and social impact assessment ("ESIA") process, including the hydrogeological assessment and dam breach analysis; the anticipated completion of environmental baseline, technical and permitting workstreams; the Company's ability to obtain required permits, approvals and authorizations; the anticipated benefits of completed environmental and technical studies, including the Air Quality Assessment; the timing and completion of future project milestones; the future development, construction and operation of the Lac Knife Project; the role of the Project in supporting North American and allied critical mineral supply chains; and the Company's long-term development strategy.Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, risks related to market conditions, regulatory approvals, changes in economic conditions, the ability to raise sufficient funds on acceptable terms or at all, operational risks associated with mineral exploration and development, and other risks detailed from time to time in the Company's public disclosure documents available under its profile on SEDAR+.The forward-looking information contained in this release is made as of the date hereof, and the Company is not obligated to update or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties, and assumptions contained herein, investors should not place undue reliance on forward-looking information.Neither TSX Venture Exchange nor its Regulation Services accepts responsibility for the adequacy or accuracy of this release.To view the source version of this press release, please visit https://www.newsfilecorp.com/release/300471 Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com